Please also visit GetIPT.com

Site outline:
Choosing IPT
Find a Doctor
IPT Training
About IPT
Other Diseases
Doctors Listing
Patient Stories
Patients Home
Articles & pubs
Site Index
About Us
Tell a Friend

This level:  






[For the historic record, here is the entire first IPT website, just one page.   It was put on Tijuana Net for Dr. Perez Garcia 3 in 1996 or 1997.  Only the email address, office address, phone area code, and office hours have been changed, along with some minor formatting.]

Cancer: Use of Biologic Response Modifiers, insulin hormone, as a neo-adjuvant anticancer drug potentiator in the treatment of some cancers.

Photo 1 : mammogram suggests
presence of infiltrating ductal carcinoma
accompanied by two palpable nodes in
the right axilla.  (February 3,1989)


Photo 2: mammogram take after the
completion of a 8 courses of
treatments with the insulin protocol
reveals complete regression of
axillary and breast masses.
(June 15,1989).

Photo 3: Initial X-ray of left arm from a 3 year old girl
diagnosed with Ewing's sarcoma of the bone
(August 17,1970)

Photo 4: Follow-up X-ray of left arm, 8 years post-treatment
(September 1978)

   Complete tumor regression has been achieved without surgery or radiotherapy in patients with some types of cancer using insulin as a biological response modifier combined with reduced doses of anticancer drugs. This treatment resulted in marked reduction of dose-related side effects caused by the anticancer drugs.

Administering pharmacological doses of exogenous insulin to patients with some types of cancer and, at the onset of hypoglycemia, follow this with low doses of anticancer drugs. Drug potentiation results from an insulin induced increase in trans-membrane passage allowing for greater intracellular concentration of drug. The technique has been pioneered by the late Dr. Donato Perez Garcia, Sr., his son and grandson- Dr. Donato Perez Garcia y Bellon and   Dr. Donato Perez Garcia, working in Mexico. Their initial clinical trials started back in 1948. Dr, SGA, of the Chicago Medical School, North Chicago, Illinois has been following closely these technique, developed by the Dr. Perez, since 1975. He has confirmed the safety and efficacy of the insulin as a neo-adjuvant anticancer drug potentiator in the treatment of some cancer's producing dramatic complete and long-term regression of tumor masses in all subjects without adverse effects and with excellent cosmetic results in the case of breast cancer. Even Dr. M. Fink, from Klinikum Furth in Germany, had good results with the treatment of metastatic cancer, using the technique developed by the Dr. Perez, noticing a 70% decrease in  the tumor volume after a 10 day follow-up. (January 22,1992).


Email to: DonatoPG3@yahoo.com

Dr. Donato Perez Garcia

Blvd.Agua Caliente #4558-C1-8

Tijuana, B.C. 22420 Mexico

Phone (from US): O11-52-(664)686-5473

FAX: (664) 686-1423

[Monday - Friday 9am - 5pm.

Scientific References -Medical Journals-: (l.-)Revista Medica Militar 1938; volume 1, number 2:1-70. ; (2.-)Medical Hypotheses 20(2):199-210, 1986.; (3.-)Res Commun Chem Pathol Pharmacol 63(1):45-52,1989.; (4.-)Medical Hypotheses 29:283-291, i 989.; (5.-)European Journal of Cancer, 26,1262-1263, 1990.

Lectures at Scientific Conventions: (1.-)Forty-second Annual Symposium on Fundamental Cancer Research, The University of Texas,M.D.Anderson Cancer Center, October 24-27,1989.; (2.-)Third International Congress on Neoadjuvant Chemotherapy, Paris, France, February 6-9, 1991.

Historical Materials:(1.-) TIME Magazine article, April 10,1944.


This level:  

Site index: 

Tell a friend about IPTQ.com
Entire IPTQ website Copyright 1999-2002 by Chris Duffield, Ph.D.  All rights reserved.
IPTQ, IPTQ.org, IPTQ.com, IPTQ.net, The second discovery of insulin, and IPTQ lifering and lifeboat logos are trademarks. 
Please read the IPTQ.com disclaimer.   
This page was last updated on  March 19, 2008.
Website technical corrections and suggestions -- email to IPTQ Webhost.
Please also visit GetIPT.com
website visitors since August 2002
Click on box for detailed statistics)

Chris Duffield, webhost